December #108 : Trouble in Mind - by Carmen Retzlaff

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents

Detectable Rebels

Now See This

Editor's Letter-December 2004

Mailbox-December 2004

Down on the Pharma

Show and Tell

Pushing the Envelope

First, the Bad News

Milestones

Faster Forward

Prince Valiant

POS/NEG

Pregnant Pauses

Moonlighting Statins

They Soothe Tootsies, Don’t They?

Trouble in Mind

Pharm School

View from the Top



Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

December 2004

Trouble in Mind

by Carmen Retzlaff

Helping HIVers with mental or emotional issues: Treat creatively, and keep it under one roof

Living with HIV is hard enough—but add cognitive or emotional disorders, and your days can be truly lousy. Such folks in Rochester, New York, find help at the AIDS Community Health Center, with social workers; a dietitian; and medical, mentalhealth and chemical-dependency staff all on one floor. That way, says ACHC medical director Michael Christie, MD, HIVers with multiple diagnoses, like brain damage and schizophrenia, needn’t tackle a maze of buses and elevators to get from one appointment to the next—and they get help from a full-time treatment-adherence team.

Christie says it’s crucial to “meet people where they are and match our resources to [their] needs.” This includes visiting HIVers who’ve moved from group homes into individual apartments to help them take their meds (“without making them feel they’re being treated like children,” he adds). It also requires a generous dose of outside-the-box thinking: “The reality is [we have to] deal with everything at once,” Christie says. “So we use a kind of risk-reduction model—frequently making it up as we go.”

You might expect Christie to avoid prescribing Sustiva (efavirenz) to this group of HIVers, because of its psychotropic side effects—from “vivid dreams” to depression. But he says it’s often a good choice because it can be dosed once daily, helping with adherence. Christie makes it work by “close monitoring”—arranging regular phone calls from doctors to Sustiva-takers, sticking close by while they go through the (often temporary) complications.

Flexibility counts. “We consider variations in the standard or ideal treatment,” says Christie. “We might be willing to settle for [meds taken] five days out of seven, knowing that on the weekend when someone is not handing them a pill, they won’t get it.” He adds, “I’m willing to settle for detectable [viral loads] rather than seeing the person end up in the ICU.” Now, that’s reality HIV.




[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Are you buying holiday gifts that raise HIV/AIDS awareness?
Yes
No

Survey
Smoke Signals

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.